JP2551471B2 - Glyceryl ether derivative and skin external preparation containing the same - Google Patents
Glyceryl ether derivative and skin external preparation containing the sameInfo
- Publication number
- JP2551471B2 JP2551471B2 JP25561288A JP25561288A JP2551471B2 JP 2551471 B2 JP2551471 B2 JP 2551471B2 JP 25561288 A JP25561288 A JP 25561288A JP 25561288 A JP25561288 A JP 25561288A JP 2551471 B2 JP2551471 B2 JP 2551471B2
- Authority
- JP
- Japan
- Prior art keywords
- skin
- external preparation
- mol
- glyceryl ether
- ether derivative
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Dermatology (AREA)
- Emergency Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Cosmetics (AREA)
Description
【発明の詳細な説明】 〔産業上の利用分野〕 本発明はグリセリルエーテル誘導体及びそれを含有す
る皮膚外用剤、更に詳しくは角層の水分保持力を高め、
肌あれを改善することができる皮膚外用剤に関する。DETAILED DESCRIPTION OF THE INVENTION [Industrial field of application] The present invention relates to a glyceryl ether derivative and an external preparation for skin containing the same, more specifically to enhance the water-retaining power of the stratum corneum.
The present invention relates to a skin external preparation capable of improving rough skin.
従来、肌にうるおいを与え、肌を柔軟にするには、角
質層の水分が重要であることが知られている。そして、
当該水分の保持は、角質層に含まれている水溶性成分、
すなわち遊離アミノ酸、有機酸、尿素又は無機イオンに
よるものであるとされ、これら物質は単独であるいは組
合せて薬用皮膚外用剤あるいは化粧料に配合して、肌あ
れの改善又は予防の目的で使用されている。BACKGROUND ART Conventionally, it is known that the moisture of the stratum corneum is important for providing moisture to the skin and making the skin soft. And
Retention of the water is the water-soluble component contained in the stratum corneum,
That is, it is said to be caused by free amino acids, organic acids, urea or inorganic ions, and these substances are used alone or in combination in a medicated external preparation for skin or cosmetics for the purpose of improving or preventing skin roughness. There is.
また、これとは別に水と親和性が高い多くの保湿性物
質が開発され、同様の目的で使用されている。In addition to this, many moisturizing substances having high affinity with water have been developed and used for the same purpose.
〔発明が解決しようとする課題〕 しかしながら、これらの保湿性物質は、皮膚に適用し
た場合、その作用は、皮膚角質層上にあつて水分を角質
に供給するというもので、しかもその効果は一時的であ
り、根本的に角質層の水分保持能力を改善し、肌あれを
本質的に予防あるいは治癒させるというものではなかつ
た。[Problems to be Solved by the Invention] However, when these moisturizing substances are applied to the skin, the action is to supply water to the horny layer on the stratum corneum of the skin, and its effect is temporary. However, it does not fundamentally improve the water retention capacity of the stratum corneum and essentially prevent or cure the rough skin.
斯かる実情において、本発明者らは上記問題点を解決
すべく鋭意研究を行つたところ、今回本発明者らによつ
て初めて合成された次の一般式(I) (式中、R1は を示し、R2は水素原子、炭素数1〜26の直鎖若しくは分
岐鎖の飽和若しくは不飽和の炭化水素基または基−CH2C
H(OH)CH2OHを示す) で表わされるグリセリルエーテル誘導体が角質層の水分
保持能力を根本的に改善する効果を有すること、そして
このグリセリルエーテル誘導体に界面活性剤を併用する
とその効果を更に増大できることを見出し、本発明を完
成した。Under such circumstances, the inventors of the present invention have conducted diligent research to solve the above-mentioned problems. As a result, the following general formula (I) synthesized by the present inventors for the first time has been shown. (In the formula, R 1 is R 2 represents a hydrogen atom, a linear or branched saturated or unsaturated hydrocarbon group having 1 to 26 carbon atoms or a group —CH 2 C
H (OH) CH 2 OH) has the effect of fundamentally improving the water-retaining capacity of the stratum corneum, and the combined use of a surfactant with this glyceryl ether derivative further enhances the effect. The inventors have found that they can be increased and have completed the present invention.
すなわち本発明は、前記式(I)で表わされるグリセ
リルエーテル誘導体、それを1種または2種以上含有す
る皮膚外用剤及び前記式(I)で表わされるグリセリル
エーテル誘導体1種または2種以上と界面活性剤を含有
する皮膚外用剤を提供するものである。That is, the present invention provides a glyceryl ether derivative represented by the above formula (I), a skin external preparation containing one or two or more kinds thereof, and an interface with one or more glyceryl ether derivatives represented by the above formula (I). The present invention provides an external preparation for skin containing an active agent.
本発明の一般式(I)で表わされるグリセリルエーテ
ル誘導体は、公知の方法(例えば、特開昭56−133281
号、同59−175445号、同59−93022号、同56−81456号公
報等)に準じて製造することができる。The glyceryl ether derivative represented by the general formula (I) of the present invention can be prepared by a known method (for example, JP-A-56-133281).
No. 59-175445, No. 59-93022, No. 56-81456, etc.).
すなわち、一般式(I)においてR2が水素原子である
グリセリルエーテル誘導体(Ia)は、例えば下記反応式
に従つて、アビエチルアルコール類(II)に塩素基存在
下でエピクロルヒドリンを作用させてグリシジルエーテ
ル誘導体(III)とし、次いでこれをルイス酸触媒存在
下でアセトンを使用させてジオキソラン誘導体(IV)と
したのち酸触媒存在下で加水分解するか、または3級ア
ミンの存在下に無水酢酸を作用させてジアセテート誘導
体(V)としたのち塩基存在下で加水分解することによ
り製造される。That is, a glyceryl ether derivative (Ia) in which R 2 is a hydrogen atom in the general formula (I) can be obtained by reacting epichlorohydrin on an abiethyl alcohol (II) in the presence of a chlorine group according to the following reaction formula. The ether derivative (III) is converted to a dioxolane derivative (IV) by using acetone in the presence of a Lewis acid catalyst and then hydrolyzed in the presence of an acid catalyst, or acetic anhydride is added in the presence of a tertiary amine. It is produced by reacting it to form the diacetate derivative (V) and then hydrolyzing it in the presence of a base.
(ここで、R1は前記した意味を表わす) また、一般式(I)においてR2が炭素数1〜26の直鎖
若しくは分岐鎖の飽和若しくは不飽和の炭化水素基であ
るグリセリルエーテル誘導体(Ib)は、例えば下記反応
式に従つて、上記の方法で得たグリシジルエーテレ誘導
体(III)に塩基触媒の存在下でアルコール(VI)を作
用させることにより製造される。 (Here, R 1 represents the above-mentioned meaning) Further, in the general formula (I), R 2 is a glyceryl ether derivative in which R 2 is a linear or branched saturated or unsaturated hydrocarbon group having 1 to 26 carbon atoms ( Ib) is produced, for example, by reacting the glycidyl ethereal derivative (III) obtained by the above method with an alcohol (VI) in the presence of a base catalyst according to the following reaction formula.
(ここで、R1は前記した意味を表わし、R2′は炭素数1
〜26の直鎖若しくは分岐鎖の飽和若しくは不飽和の炭化
水素基を表わす) 更に、一般式(I)において、R2が基 −CH2CH(OH)CH2OHであるグリセリルエーテル誘導体
(Ic)は、例えば下記反応式に従つて、前記の方法で得
たグリシジルエーテル誘導体(III)に対して塩基の存
在下1,2−ジ−O−インプロピリデングリセリンを作用
させてジオキソラン誘導体(VII)とし、次いで酸触媒
存在下で加水分解することにより製造される。 (Here, R 1 has the above-mentioned meaning, and R 2 ′ has 1 carbon atom.
~ 26 represents a straight chain or branched chain saturated or unsaturated hydrocarbon group) Further, in the general formula (I), R 2 is a group —CH 2 CH (OH) CH 2 OH. ) Is a dioxolane derivative (VII) obtained by reacting glycidyl ether derivative (III) obtained by the above-mentioned method with 1,2-di-O-impropylideneglycerin in the presence of a base according to the following reaction formula. ) And then hydrolyzing in the presence of an acid catalyst.
(ここで、R1は前記した意味を表わす) なお、上記製造方において、原料となるアビエチルア
ルコール類(II)はロジン(松脂)、またはそれを精製
することによつて得られるアビエチン酸より公知の方法
〔例えば、米国特許2,146,897号、同2,358,235号明細
書、ジャーナル オブ オルガニツク ケミスリー(J.
Org. Chem.)第34巻3464頁(1969)、木材学会誌第2
7巻649頁(1981)等〕で製造することができる。 (Here, R 1 represents the above-mentioned meaning.) In the above production method, the raw material abiethyl alcohol (II) is rosin (pine resin) or abietic acid obtained by purifying it. Known methods (for example, U.S. Pat.Nos. 2,146,897 and 2,358,235, Journal of Organism Chemistry (J.
Org. Chem.) Vol. 34, p. 3464 (1969), Mokuzai Gakkaishi No. 2
7 p. 649 (1981), etc.].
本発明のグリセリルエーテル誘導体(I)は、いずれ
も皮膚外用剤の有効成分として用いることができる。Any of the glyceryl ether derivative (I) of the present invention can be used as an active ingredient of a skin external preparation.
グリセリルエーテレ誘導体(I)の本発明皮膚外用剤
への配合量は、特に制限されないが、通常乳化型の皮膚
外用剤の場合には全組成の0.001〜50重量%(以下単に
%で示す)、特に0.1〜20%が好ましく、またスクワラ
ン等の液状炭化水素を基剤とする油性の皮膚外用剤の場
合には1〜50%、特に5〜25%が好ましい。The amount of the glyceryl ethereal derivative (I) to be added to the skin external preparation of the present invention is not particularly limited, but in the case of an emulsified skin external preparation, it is usually 0.001 to 50% by weight (hereinafter simply indicated as%) of the total composition. In particular, 0.1 to 20% is preferable, and 1 to 50%, particularly 5 to 25% is preferable in the case of oily external preparation for skin based on liquid hydrocarbon such as squalane.
また、本発明の皮膚外用剤には、その効果の増強のた
めに界面活性剤を配合してもよい。本発明に用いられる
界面活性剤としては、非イオン界面活性剤、陰イオン界
面活性剤、両性界面活性剤の何れをも使用できるが、就
中特に非イオン界面活性剤が好適である。Further, the external preparation for skin of the present invention may contain a surfactant for enhancing its effect. As the surfactant used in the present invention, any of a nonionic surfactant, an anionic surfactant and an amphoteric surfactant can be used, and among them, a nonionic surfactant is particularly preferable.
非イオン界面活性剤としては、例えばポリオキシエチ
レンアルキルエーテレ、ポリオキシエチレンアルキルフ
エニルエーテレ、ポリオキシエチレン脂肪酸エステル、
ソルビタン脂肪酸エステル、ポリオキシエチレンソルビ
タン脂肪酸エステル、脂肪酸モノグリセライド、グリセ
リルエーテル等が挙げられる。その中でも、対の一般式
(VIII) (式中、Rは炭素数8〜24のアルキル基を示す) で表されるグリセリルエーテレ、就中Rが次式(IX) (式中、pは4〜10の整数、qは5〜11の整数を示し、
p+q=11〜17でp=7、q=8を頂点とする分布を有
する) で表わされるものが特に好ましい。As the nonionic surfactant, for example, polyoxyethylene alkyl ether, polyoxyethylene alkyl phenyl ether, polyoxyethylene fatty acid ester,
Examples thereof include sorbitan fatty acid ester, polyoxyethylene sorbitan fatty acid ester, fatty acid monoglyceride and glyceryl ether. Among them, the pair of general formula (VIII) (In the formula, R represents an alkyl group having 8 to 24 carbon atoms), wherein R is the following formula (IX) (In the formula, p represents an integer of 4 to 10, q represents an integer of 5 to 11,
(p + q = 11 to 17 and a distribution having p = 7 and q = 8 as vertices) is particularly preferable.
界面活性剤の配合量は、全組成の0.01〜20%、特に0.
1〜5%が好ましい。The content of the surfactant is 0.01 to 20% of the total composition, and especially 0.
1-5% is preferable.
本発明の皮膚外用剤は、その使用形態において、薬用
皮膚外用剤と化粧料に大別される。The external preparation for skin of the present invention is roughly classified into a medicated external preparation for skin and a cosmetic in its use form.
薬用皮膚外用剤としては、例えば薬効成分を含有する
各種軟膏剤を挙げることができる。軟膏剤としては、油
性基剤をベースとするもの、油/水、水/油型の乳化系
基剤をベースとするもののいずれであつてもよい。油性
基剤としては、特に制限はなく、例えば植物油、動物
油、合成油、脂肪酸、天然又は合成のグリセライド等が
挙げられる。また薬効成分としては、特に制限はなく、
例えば鎮痛消炎剤、鎮痒剤、殺菌消毒剤、収歛剤、皮膚
軟化剤、ホルモン剤等を必要に応じて適宜使用すること
ができる。Examples of the medicated skin external preparation include various ointments containing a pharmaceutically active ingredient. The ointment may be any of those based on an oily base and those based on an oil / water or water / oil type emulsified base. The oily base is not particularly limited, and examples thereof include vegetable oil, animal oil, synthetic oil, fatty acid, natural or synthetic glyceride, and the like. The medicinal component is not particularly limited,
For example, an analgesic anti-inflammatory agent, an antipruritic agent, a bactericidal disinfectant, an astringent agent, an emollient agent, a hormone agent and the like can be appropriately used as necessary.
また、化粧料として使用する場合は、必須成分の他に
化粧料成分として一般に使用されている油分、保湿剤、
紫外線吸収剤、アルコール類、キレート剤、pH調整剤、
腐食剤、増粘剤、色素、香料等を任意に組み合わせて配
合することができる。When used as a cosmetic, in addition to the essential ingredients, oils, moisturizers, which are generally used as cosmetic ingredients,
UV absorbers, alcohols, chelating agents, pH adjusters,
A corrosive agent, a thickener, a pigment, a fragrance and the like can be arbitrarily combined and blended.
化粧料としては、種々の形態、例えば水/油、油/水
型乳化化粧料、クリーム、化粧乳液、化粧水、油性化粧
料、口紅、フアウンデーシヨン、皮膚洗浄剤、ヘアート
ニツク、整髪剤、養毛剤、育毛剤等の皮膚化粧料とする
ことができる。As cosmetics, various forms such as water / oil, oil / water type emulsified cosmetics, creams, emulsions, lotions, oily cosmetics, lipsticks, foundations, skin cleansers, hair nicks, hair styling agents, It can be used as a skin cosmetic such as a hair restorer and a hair restorer.
本発明皮膚外用剤における式(I)で示されるグリセ
リルエーテル誘導体の作用機構の詳細は完全には解明さ
れていないが、これが角質細胞間に脂質膜を再構築して
角質層の水分保持機能を発揮するものと考えられる。Although the details of the mechanism of action of the glyceryl ether derivative represented by the formula (I) in the external preparation for skin of the present invention have not been completely elucidated, this reconstructs a lipid membrane between corneocytes to improve the water retention function of the stratum corneum. It is considered to be effective.
本発明皮膚外用剤は、このような作用を有するグリセ
リルエーテル誘導体(I)を含有するものであるため、
肌あれに対して優れた改善及び予防効果を発揮すること
ができる。Since the external preparation for skin of the present invention contains the glyceryl ether derivative (I) having such an action,
It is possible to exert excellent improvement and preventive effects on the rough skin.
次に実施例を挙げて説明する。 Next, examples will be described.
実施例1 1−O−アビエチルグリセリン(一般式(I)におい
てR1が基(B)であり、R2が水素原子であるグリセリル
エーテル誘電体)の合成: (a) 還流冷却器、温度計、滴下ロート、N2ガス導入
管及び撹拌装置を備えた1フラスコに、アビエチルア
ルコール115.4g(0.4mol)、トルエン115.4g.エピクロ
ルヒドリン111.0g(1.2mol)及び硫酸水素テトラ−n−
ブチルアンモニウム6.79g(0.02mol)の50重量%水溶液
を仕込み、N2ガス導入下、撹拌しながら40℃に加温し
た。ここに水酸化ナトリウム80g(2mol)の50%水溶液
を、激しく撹拌しながら30分かけて滴下し、次いで反応
混合物の温度を50℃に昇温して5時間撹拌を行つた。こ
こで生成した食塩を除くために反応混合物を水洗しさら
に、エピクロルヒドリン92.5g(0.24mol)及び硫酸水素
テトラ−n−ブチルアンモニウム1.36g(0.004mol)を
加えて再び40℃に加温した。次いでここに水酸化ナトリ
ウム80g(2mol)の50%水溶液を、激しく撹拌しながら3
0分かけて滴下し、反応混合物の温度を50℃に昇温して
さらに5時間撹拌した。反応終了後、反応混合物を水
洗、減圧蒸留してアビエチルグリシジルエーテル117.0g
(収率84.9%)を得た。Example 1 Synthesis of 1-O-abiethylglycerin (glyceryl ether dielectric in which R 1 is a group (B) and R 2 is a hydrogen atom in the general formula (I)): (a) Reflux condenser, temperature In a flask equipped with a meter, a dropping funnel, a N 2 gas introduction tube and a stirring device, 115.4 g (0.4 mol) of abiethyl alcohol, 115.4 g of toluene, 111.0 g (1.2 mol) of epichlorohydrin and tetra-n-hydrogen sulfate.
A 50% by weight aqueous solution of butylammonium 6.79 g (0.02 mol) was charged, and the mixture was heated to 40 ° C. with stirring under N 2 gas introduction. A 50% aqueous solution of 80 g (2 mol) of sodium hydroxide was added dropwise over 30 minutes with vigorous stirring, then the temperature of the reaction mixture was raised to 50 ° C. and stirring was carried out for 5 hours. The reaction mixture was washed with water in order to remove the sodium chloride produced here, and 92.5 g (0.24 mol) of epichlorohydrin and 1.36 g (0.004 mol) of tetra-n-butylammonium hydrogensulfate were added and the mixture was heated again to 40 ° C. Next, add 80 g (2 mol) of sodium hydroxide to a 50% aqueous solution while stirring vigorously.
The mixture was added dropwise over 0 minutes, the temperature of the reaction mixture was raised to 50 ° C., and the mixture was further stirred for 5 hours. After completion of the reaction, the reaction mixture was washed with water and distilled under reduced pressure to obtain 117.0 g of abiethyl glycidyl ether.
(Yield 84.9%) was obtained.
沸点:148〜174℃(0.001Torr.) IR(cm-1):2926,1467,1386,1101,918,891,849 NMR(CDCl3,δppm):0.81(s,3H),0.88(s,3H),1.00
(d,J=6.6Hz,3H),1.01(d,J=6.6Hz,3H),1.10〜1.70
(m,7H),1.70〜2.15(m,7H),2.21(qq,J=6.6,6.6Hz,
1H),2.53〜2.58(m,1H),2.75(t,J=4.8Hz,1H),2.97
(dd,J=18.0,8.8Hz,1H),3.04〜3.12(m,1H),3.21(d
d,J=18.0,8.8Hz,1H),3.28〜3.37(m,1H),3.65(dd,J
=11.7,2.9Hz,1H),5.39(s,1H),5.77(s,1H) (b) 還流冷却器、温度計、N2ガス導入管及び撹拌装
置を備えた1フラスコに、無水酢酸306.3g(3mol)、
トリエチルアミン12.1g(0.12mol)及び上記(a)で得
たアビエチルグリシジルエーテル103.4g(0.3mol)を仕
込み、N2ガス導入下100℃で15時間加熱撹拌した。冷却
後、反応混合物を水に加え、ジエチルエーテルで生成物
を抽出し、溶媒を減圧下に留去して1−O−アビエチル
−2,3−ジ−O−アセチルグリセリン粗製物を得た。Boiling point: 148-174 ° C (0.001 Torr.) IR (cm -1 ): 2926,1467,1386,1101,918,891,849 NMR (CDCl 3 , δppm): 0.81 (s, 3H), 0.88 (s, 3H), 1.00
(D, J = 6.6Hz, 3H), 1.01 (d, J = 6.6Hz, 3H), 1.10 to 1.70
(M, 7H), 1.70 to 2.15 (m, 7H), 2.21 (qq, J = 6.6,6.6Hz,
1H), 2.53 to 2.58 (m, 1H), 2.75 (t, J = 4.8Hz, 1H), 2.97
(Dd, J = 18.0,8.8Hz, 1H), 3.04〜3.12 (m, 1H), 3.21 (d
d, J = 18.0,8.8Hz, 1H), 3.28 to 3.37 (m, 1H), 3.65 (dd, J
= 11.7, 2.9Hz, 1H), 5.39 (s, 1H), 5.77 (s, 1H) (b) One flask equipped with a reflux condenser, a thermometer, a N 2 gas inlet tube, and a stirrer was charged with acetic anhydride 306.3 g (3mol),
12.1 g (0.12 mol) of triethylamine and 103.4 g (0.3 mol) of abiethyl glycidyl ether obtained in the above (a) were charged, and the mixture was heated and stirred at 100 ° C. for 15 hours while introducing N 2 gas. After cooling, the reaction mixture was added to water, the product was extracted with diethyl ether, and the solvent was evaporated under reduced pressure to give 1-O-abiethyl-2,3-di-O-acetylglycerin crude product.
(c) 還流冷却器、N2ガス導入管及び撹拌装置を備え
た1フラスコに、上記(b)で得た1−O−アビエチ
ル−2,3−ジ−O−アセチルグリセリン粗製物、エタノ
ール200g及び水酸化ナトリウム60g(1.5mol)の30重量
%水溶液を仕込み、N2ガス導入下12時間加熱還流した。
反応終了後、溶媒を減圧留去し、残渣をジエチルエーテ
ルに溶解して食塩水で洗浄し、ジエチルエーテルを留去
した後、シリカゲルカラムクロマトグラフイーで精製す
ることにより、目的の1−O−アビエチルグリセリン7
8.3g((b)よりの収率72.0%)を無色粘稠油状物とし
て得た。(C) 1-O-abiethyl-2,3-di-O-acetylglycerin crude product obtained in (b) above, 200 g of ethanol in one flask equipped with a reflux condenser, N 2 gas introduction tube and stirring device. A 30% by weight aqueous solution of sodium hydroxide (60 g, 1.5 mol) was charged, and the mixture was heated under reflux for 12 hours while introducing N 2 gas.
After completion of the reaction, the solvent was distilled off under reduced pressure, the residue was dissolved in diethyl ether and washed with saline, and the diethyl ether was distilled off, followed by purification by silica gel column chromatography to obtain the desired 1-O- Abiethyl glycerin 7
8.3 g (72.0% yield from (b)) was obtained as a colorless viscous oil.
IR(cm-1):3412,2932,1467,1386,1119,1047,891 NMR(CDCl3,δppm):0.80(s.3H),0.88(s,3H),1.00
(d,J=7.0Hz,3H),1.01(d,J=6.6Hz,3H),1.10〜1.67
(m,7H),1.70〜2.12(m,7H),2.21(qq,J=7.0,6.6Hz,
1H),2.92〜3.01(m,1H),3.08〜3.27(m,3H),3.42
(d,J=5.1Hz,2H),3.51〜3.73(m,2H),3.82(bs,1
H),5.38(s,1H),5.76(s,1H) 実施例2 1−O−テトラヒドロアビエチルグリセリン(一般式
(I)においてR1が基(A)であり、R2が水素原子であ
るグリセリルエーテル誘導体)の合成: (a) 実施例1の(a)において、アビエチルアルコ
ール115.4g(0.4mol)の代わりにテトラヒドロアビエチ
ルアルコール117.0g(0.4mol)を用いた以外は実施例1
の(a)と同様にして、テトラヒドロアビエチルグリシ
ジルエーテル99.6g(収率71.4%)を得た。IR (cm -1 ): 3412,2932,1467,1386,1119,1047,891 NMR (CDCl 3 , δppm): 0.80 (s.3H), 0.88 (s, 3H), 1.00
(D, J = 7.0Hz, 3H), 1.01 (d, J = 6.6Hz, 3H), 1.10 to 1.67
(M, 7H), 1.70 to 2.12 (m, 7H), 2.21 (qq, J = 7.0,6.6Hz,
1H), 2.92 to 3.01 (m, 1H), 3.08 to 3.27 (m, 3H), 3.42
(D, J = 5.1Hz, 2H), 3.51 to 3.73 (m, 2H), 3.82 (bs, 1
H), 5.38 (s, 1H), 5.76 (s, 1H) Example 2 1-O-tetrahydroabietylglycerin (in the general formula (I), R 1 is a group (A) and R 2 is a hydrogen atom) Synthesis of a certain glyceryl ether derivative: (a) Example 1 except that 117.0 g (0.4 mol) of tetrahydroabietyl alcohol was used in place of 115.4 g (0.4 mol) of abiethyl alcohol in (a) of Example 1.
In the same manner as in (a) above, 99.6 g (yield 71.4%) of tetrahydroabietyl glycidyl ether was obtained.
沸点:155〜165℃(0.001Torr.) IR(cm-1):2932,2868,1456,1386,1104,848 NMR(CDCl3,δppm):0.55〜2.10(m,33H),2.58(dd,J
=5.1,2.9Hz,1H),2.75,(dd,J=5.1,4.4Hz,1H),2.96
(dd,J=14.7,8.8Hz,1H),3.04〜3.13(m,1H),3.22(d
d,J=14.7,8.8Hz,1H),3.29〜3.42(m,1H),3.60〜3.71
(m,1H) (b) 還流冷却器、温度計、滴下ロート、N2ガス導入
管及び撹拌装置を備えた500mlフラスコに、アセトン174
g(3mol)及び三フッ化ホウ素エーテル錯体1.42g(0.01
mol)を仕込み、N2ガス導入下に撹拌した。次いで上記
(a)で得たテトラヒドロアビエチルグリシジルエーテ
ル69.7g(0.2mol)のアセトン58g(1mol)溶液を撹拌下
に30分かけて滴下し、さらに1時間そのまま撹拌を続け
た。反応終了後、炭酸水素ナトリウム、1.68g(0.02mo
l)を加えてさらに30分撹拌して反応混合物を中和後、
アセトンを減圧留去した。次いで残渣をジエチルエーテ
ルに溶解し、水洗した後、溶媒を減圧留去して2,2−ジ
メチル−4−(テトラヒドロアビエチルオキシメチル)
−1,3−ジオキソラン粗製物を得た。Boiling point: 155 ~ 165 ℃ (0.001 Torr.) IR (cm -1 ): 2932, 2868, 1456, 1386, 1104, 848 NMR (CDCl 3 , δppm): 0.55 ~ 2.10 (m, 33H), 2.58 (dd, J
= 5.1,2.9Hz, 1H), 2.75, (dd, J = 5.1,4.4Hz, 1H), 2.96
(Dd, J = 14.7,8.8Hz, 1H), 3.04〜3.13 (m, 1H), 3.22 (d
d, J = 14.7,8.8Hz, 1H), 3.29 to 3.42 (m, 1H), 3.60 to 3.71
(M, 1H) (b) In a 500 ml flask equipped with a reflux condenser, a thermometer, a dropping funnel, a N 2 gas introducing tube and a stirring device, acetone 174
g (3 mol) and boron trifluoride ether complex 1.42 g (0.01
mol) was charged and the mixture was stirred under introduction of N 2 gas. Then, a solution of 69.7 g (0.2 mol) of tetrahydroabiethyl glycidyl ether obtained in (a) above in 58 g (1 mol) of acetone was added dropwise with stirring over 30 minutes, and the stirring was continued for another 1 hour. After the reaction was completed, sodium hydrogen carbonate, 1.68 g (0.02mo
l) and stirred for another 30 minutes to neutralize the reaction mixture,
Acetone was distilled off under reduced pressure. Then, the residue was dissolved in diethyl ether, washed with water, and the solvent was distilled off under reduced pressure to give 2,2-dimethyl-4- (tetrahydroabiethyloxymethyl).
A crude 1,3-dioxolane was obtained.
(c) 還流冷却器、温度計、N2ガス導入管及び撹拌装
置を備えた500mlフラスコに、上記(b)で得た2,2−ジ
メチル−4−(テトラヒドロアビエチルオキシメチル)
−1,3−ジオキソラン粗製物、メタノール63g、硫酸1.57
g(0.016mol)及び水157gを仕込み、N2ガス導入下4時
間加熱還流した。反応終了後、反応混合物をジエチルエ
ーテルで抽出し、有機層を水洗した後、溶媒を減圧留去
し、残渣をシリカゲルカラムクロマトグラフイーで精製
することにより、目的の1−O−テトラヒドロアビエチ
ルグリセリン44.6g((b)より収率60.8%)を無色粘
稠油状物として得た。(C) In a 500 ml flask equipped with a reflux condenser, a thermometer, a N 2 gas introduction tube and a stirring device, 2,2-dimethyl-4- (tetrahydroabietyloxymethyl) obtained in (b) above was added.
-1,3-dioxolane crude product, methanol 63g, sulfuric acid 1.57
g (0.016 mol) and 157 g of water were charged, and the mixture was heated under reflux for 4 hours while introducing N 2 gas. After completion of the reaction, the reaction mixture was extracted with diethyl ether, the organic layer was washed with water, the solvent was evaporated under reduced pressure, and the residue was purified by silica gel column chromatography to obtain the desired 1-O-tetrahydroabietylglycerin. 44.6 g (60.8% yield from (b)) was obtained as a colorless viscous oil.
IR(cm-1):3406,2950,1458,1386,1113,1050 NMR(CDCl3,δppm):0.55〜2.05(m,33H),2.49(bs,1
H),2.74(t,J=5.1Hz,1H),2.94(dd,J=8.8,4.0Hz,1
H),3.15〜3.25(m,1H),3.40〜3.55(m,2H),3.59〜3.
78(m,2H),3.80〜3.91(m,1H) 実施例3 1−O−デヒドロアビエチルグリセリン(一般式
(I)においてR1が基(C)であり、R2が水素原子であ
るグリセリルエーテル誘導体)の合成: (a) 実施例1の(a)において、アビエチルアルコ
ール115.4g(0.4mol)の代わりにデヒドロアビエチルア
ルコール114.6g(0.4mol)を用いた以外は実施例1の
(a)と同様にして、テヒドロアビエチルグリシジルエ
ーテル84.4g(収率61.6%)を得た。IR (cm -1 ): 3406,2950,1458,1386,1113,1050 NMR (CDCl 3 , δppm): 0.55 to 2.05 (m, 33H), 2.49 (bs, 1
H), 2.74 (t, J = 5.1Hz, 1H), 2.94 (dd, J = 8.8, 4.0Hz, 1
H), 3.15 to 3.25 (m, 1H), 3.40 to 3.55 (m, 2H), 3.59 to 3.
78 (m, 2H), 3.80 to 3.91 (m, 1H) Example 3 1-O-dehydroabietylglycerin (in the general formula (I), R 1 is a group (C) and R 2 is a hydrogen atom) Synthesis of (glyceryl ether derivative): (a) Example 1 (a) except that 114.6 g (0.4 mol) of dehydroabietyl alcohol was used instead of 115.4 g (0.4 mol) of abiethyl alcohol. In the same manner as in (a), 84.4 g (yield 61.6%) of thehydrohydrobiethyl glycidyl ether was obtained.
沸点:198〜210℃(0.03Torr.) IR(cm-1):2932,2872,1464,1383,1104,826 NMR(CDCl3,δppm):0.87(s,3H),1.20(s,6H),1.23
(s,3H),1.28〜1.96(m,9H),2.25(bd,J=12.1Hz,1
H),2.51〜2.57(m,1H),2.71(dd,J=4.8,4.4Hz,1H),
2.73〜2.94(m,2H),2.95〜3.12(m,2H),3.17〜3.40
(m,2H),3.58〜3.71(m,1H),6.87(bs,1H),6.96(b
d,J=8.1Hz,1H),7.16(d,J=8.1Hz,1H) (b) 実施例2の(b)〜(c)において、テトラヒ
ドロアビエチルグリシジルエーテル69.7g(0.2mol)の
代わりにデヒドロアビエチルグリシジルエーテル68.5g
(0.2mol)を用いた以外は実施例2の(b)〜(c)と
同様にして、1−O−デヒドロアビエチルグリセリン5
9.9g(収率8.31%を得た。Boiling point: 198-210 ° C (0.03 Torr.) IR (cm -1 ): 2932,2872,1464,1383,1104,826 NMR (CDCl 3 , δppm): 0.87 (s, 3H), 1.20 (s, 6H) , 1.23
(S, 3H), 1.28 to 1.96 (m, 9H), 2.25 (bd, J = 12.1Hz, 1
H), 2.51 to 2.57 (m, 1H), 2.71 (dd, J = 4.8, 4.4Hz, 1H),
2.73 ~ 2.94 (m, 2H), 2.95 ~ 3.12 (m, 2H), 3.17 ~ 3.40
(M, 2H), 3.58 to 3.71 (m, 1H), 6.87 (bs, 1H), 6.96 (b
d, J = 8.1Hz, 1H), 7.16 (d, J = 8.1Hz, 1H) (b) In (b) to (c) of Example 2, instead of 69.7 g (0.2 mol) of tetrahydroabietyl glycidyl ether 68.5 g of dehydroabietyl glycidyl ether
1-O-dehydroabietylglycerin 5 was prepared in the same manner as in (b) to (c) of Example 2 except that (0.2 mol) was used.
9.9 g (yield 8.31% was obtained.
IR(cm-1):3406,2926,2872,1464,1383,1116,1044,822,
738 NMR(CDCl3,δppm):0.85(s,3H),1.18(s,6H),1.21
(s,3H),1.27〜2.10(m,9H),2.22(bd,J=12.1Hz,1
H),2.68〜3.03(m,3H),3.08〜3.67(m,5H),3.75(b
s,1H),3.91(s.1H),6.85(s,1H),6.94(d,J=8.1Hz,
1H),7.12(d,J=8.1Hz,1H) 実施例4 1−O−テトラヒドロアビエチル−3−O−メチルグ
リセリン(一般式(I)においてR1が基(A)であり、
R2がメチル基であるグリセリルエーテル誘導体)の合
成: 還流冷却器、滴下ロート、温度計及び撹拌装置を備え
た300mlフラスコに、メタノール100g(3.13mol)、MeON
a0.53g(0.01mol)を加え、60℃で加熱撹拌した。ここ
に実施例2(a)で得たテトラヒドロアビエチルグリジ
ルエーテル34.9g(0.1mol)を撹拌しながら2時間かけ
て滴下し、滴下終了後さらに60℃で8時間撹拌した。反
応終了後、過剰のメタノールを減圧下で留去し、残渣を
塩化アンモニウム水溶液で中和後、ジクロロメタンで抽
出した。次いで減圧下に溶媒留去した後、シリカゲルカ
ラムクロマトグラフイーで精製することにより、目的の
1−O−アビエチル−3−O−メチルグリセリン32.5g
(収率85.4%)を無色油状物として得た。IR (cm -1 ): 3406,2926,2872,1464,1383,1116,1044,822,
738 NMR (CDCl 3 , δppm): 0.85 (s, 3H), 1.18 (s, 6H), 1.21
(S, 3H), 1.27 to 2.10 (m, 9H), 2.22 (bd, J = 12.1Hz, 1
H), 2.68 ~ 3.03 (m, 3H), 3.08 ~ 3.67 (m, 5H), 3.75 (b
s, 1H), 3.91 (s.1H), 6.85 (s, 1H), 6.94 (d, J = 8.1Hz,
1H), 7.12 (d, J = 8.1 Hz, 1H) Example 4 1-O-tetrahydroabietyl-3-O-methylglycerin (in the general formula (I), R 1 is a group (A),
Synthesis of glyceryl ether derivative in which R 2 is a methyl group: 100 g of methanol (3.13 mol), MeON in a 300 ml flask equipped with a reflux condenser, a dropping funnel, a thermometer and a stirring device.
0.53 g (0.01 mol) of a was added, and the mixture was heated with stirring at 60 ° C. 34.9 g (0.1 mol) of tetrahydroabietyl glycidyl ether obtained in Example 2 (a) was added dropwise over 2 hours with stirring, and after the addition was completed, the mixture was further stirred at 60 ° C. for 8 hours. After completion of the reaction, excess methanol was distilled off under reduced pressure, the residue was neutralized with an aqueous ammonium chloride solution, and extracted with dichloromethane. Then, the solvent was distilled off under reduced pressure, and the residue was purified by silica gel column chromatography to obtain 32.5 g of the desired 1-O-abiethyl-3-O-methylglycerin.
(Yield 85.4%) was obtained as a colorless oil.
IR(cm-1):3380,2936,2868,1456,1386,1116,870 NMR(CDCl3,δppm):0.54〜2.03(m,33H),2.53(d,J=
4.0Hz,1H),2.93(dd,J=8.8,4.4Hz,1H),3.13〜3.22
(m,1H),3.32〜3.50(m,4H),3.39(s,3H),3.88〜3.9
9(m,1H) 実施例5 1−O−テトラヒドロアビエチル−3−O−メチル分
岐イソステアリルグリセリン(一般式(I)においてR1
が基(A)であり、R2がメチル分岐イソステアリル基で
あるグリセリルエーテル誘導体)の合成: 還流冷却器、滴下ロート、温度計、N2ガス導入管及び
撹拌装置を備えた300フラスコにメチル分岐イソステ
アリルアルコール(米国エメリー社製)135.3g(0.5mo
l)を仕込み、ここにN2ガス導入下でナトリウム0.81g
(0.03mol)を投入し、80℃で1時間撹拌しナトリウム
を完全に溶解した。次いで、実施例2の(a)で得たテ
トラヒドロアビエチルグリシジルエーテル34.8g(0.1mo
l)を撹拌しながら80℃で2時間かけて滴下し、滴下終
了後さらに80℃で3時間撹拌した。反応終了後、過剰の
アルコールを減圧下で留去し、残渣を塩化アンモニウム
水溶液で中和後、ジクロロメタンで抽出した。次いで減
圧下に溶媒留去しシリカゲルクロマトグラフイーで精製
することにより、目的の1−O−テトラヒドロアビエチ
ル−3−O−メチル分岐イソステアリルグリセリン51.2
g(収率82.6%)を得た。IR (cm -1 ): 3380,2936,2868,1456,1386,1116,870 NMR (CDCl 3 , δppm): 0.54 to 2.03 (m, 33H), 2.53 (d, J =
4.0Hz, 1H), 2.93 (dd, J = 8.8,4.4Hz, 1H), 3.13 to 3.22
(M, 1H), 3.32-3.50 (m, 4H), 3.39 (s, 3H), 3.88-3.9
9 (m, 1H) Example 5 1-O-tetrahydroabietyl-3-O-methyl branched isostearyl glycerin (in the general formula (I), R 1
Is a group (A) and R 2 is a methyl-branched isostearyl group) synthesis: a 300-flask equipped with a reflux condenser, a dropping funnel, a thermometer, a N 2 gas inlet tube and a stirring device. 135.3g (0.5mo) of branched isostearyl alcohol (manufactured by Emery USA)
l) was charged, and 0.81 g of sodium was introduced therein under N 2 gas introduction.
(0.03 mol) was added and the mixture was stirred at 80 ° C. for 1 hour to completely dissolve sodium. Then, 34.8 g (0.1 mol) of the tetrahydroabietyl glycidyl ether obtained in (a) of Example 2 was used.
l) was added dropwise with stirring at 80 ° C. over 2 hours, and after the completion of dropping, the mixture was further stirred at 80 ° C. for 3 hours. After completion of the reaction, excess alcohol was distilled off under reduced pressure, the residue was neutralized with an aqueous ammonium chloride solution, and extracted with dichloromethane. Then, the solvent was distilled off under reduced pressure and the residue was purified by silica gel chromatography to give the desired 1-O-tetrahydroabiet-3-O-methyl branched isostearyl glycerin 51.2.
g (yield 82.6%) was obtained.
IR(cm-1):3464,2928,2860,1466,1386,1116 NMR(CDCl3,δppm):0.53〜2.02(m,68H),24.6(d,J=
4.8Hz,1H),2.88〜3.00(m,1H),3.13〜3.26(m,1H),
3.34〜3.53(m,6H),3.91(dtt,J=5.1Hz,1H) 実施例6 1−O−テトラヒドロアビエチル−3−O−(2,3−
ジヒドロキシプロピル)−グリセリン(一般式(I)に
おいてR1が基(A)であり、R2が基−CH2CH(OH)CH2OH
であるグリセリルエーテル誘導体)の合成: (a) 実施例5において、メチル分岐イソステアリル
アルコール135.3g(0.5mol)の代わりに、2,2−ジメチ
ル−1,3−ジオキソラソ−4−メタノール132.2g(1mo
l)を用いた以外は実施例5と同様にして、4−(3−
テトラヒドロアビエチルオキシ−2−ヒドロキシプロピ
ルオキシメチル)−2,2−ジメチル−1,3−ジオキソラン
を得た。IR (cm -1 ): 3464,2928,2860,1466,1386,1116 NMR (CDCl 3 , δppm): 0.53 to 2.02 (m, 68H), 24.6 (d, J =
4.8Hz, 1H), 2.88 ~ 3.00 (m, 1H), 3.13 ~ 3.26 (m, 1H),
3.34 to 3.53 (m, 6H), 3.91 (dtt, J = 5.1Hz, 1H) Example 6 1-O-tetrahydroabietyl-3-O- (2,3-
Dihydroxypropyl) -glycerin (in the general formula (I), R 1 is a group (A) and R 2 is a group —CH 2 CH (OH) CH 2 OH
(A) In Example 5, 132.2 g of 2,2-dimethyl-1,3-dioxolaso-4-methanol (instead of 135.3 g (0.5 mol) of methyl-branched isostearyl alcohol in Example 5) 1mo
4- (3-) is the same as Example 5 except that l) is used.
Tetrahydroabiethyloxy-2-hydroxypropyloxymethyl) -2,2-dimethyl-1,3-dioxolane was obtained.
(b) 実施例2の(c)において、2,2−ジメチル−
4−(テトラヒドロアビエチルオキシメチル)−1,3−
ジオキソラン粗製物の代わりに、上記(a)で得た4−
(3−テトラヒドロアビエチルオキシ−2−ヒドロキシ
プロピルオキシメチル)−2,2−ジメチル−1,3−ジオキ
ソランを用いた以外は実施例2の(c)と同様にして、
1−0−テトラヒドロアビエチル−3−O−(2,3−ジ
ヒドロキシプロピル)−グリセリン35.8g((a)より
の収率81.3%)を得た。(B) In (c) of Example 2, 2,2-dimethyl-
4- (tetrahydroabiethyloxymethyl) -1,3-
Instead of crude dioxolane, 4-obtained in (a) above
(3-tetrahydroabiethyloxy-2-hydroxypropyloxymethyl) -2,2-dimethyl-1,3-dioxolane was used in the same manner as in Example 2 (c) except that
35.8 g of 1-0-tetrahydroabiethyl-3-O- (2,3-dihydroxypropyl) -glycerin (81.3% yield from (a)) was obtained.
IR(cm-1):3456,2932,2872,1456,1386,1112,972 NMR(CDCl3δppm):0.54〜2.05(m,33H),2.92〜3.15
(m,2H),3.12〜3,26(m,1H),3.33〜4.08(m,11H),4.
35(bs,1H) 実施例7 ワセリン/実施例1〜6の化合物=3/1(重量比)の
混合物(本発明品)とワセリンを用い、下記方法により
皮膚コンダクタンス及び肌あれについて評価した。結果
を第1表に示す。IR (cm -1 ): 3456,2932,2872,1456,1386,1112,972 NMR (CDCl 3 δppm): 0.54 to 2.05 (m, 33H), 2.92 to 3.15
(M, 2H), 3.12 to 3,26 (m, 1H), 3.33 to 4.08 (m, 11H), 4.
35 (bs, 1H) Example 7 Skin conductance and skin roughness were evaluated by the following methods using a mixture of petrolatum / compound of Examples 1 to 6 = 3/1 (weight ratio) and petrolatum. The results are shown in Table 1.
(試験方法) 冬期に頬部に肌あれを起こしている20〜50才の女性10
名を被験者とし、左右の頬に異なる皮膚外用剤を2週間
塗布する。2週間の塗布が終了した翌日に次の項目につ
き試験を行つた。(Test method) Women aged 20 to 50 who have rough skin on the cheeks in winter 10
The first name is the subject, and different skin external preparations are applied to the left and right cheeks for 2 weeks. On the day after the application for two weeks was completed, the following items were tested.
(1) 皮膚コンダクタンス 37℃の温水にて洗顔後、温度20℃、湿度40%の部屋で
20分間安静にした後、角質層の水分含有量を皮膚コンダ
クタンスメータ(IBS社製)にて測定した。コンダクタ
ンス値は値が小さいほど皮膚は肌あれし、5以下ではひ
どい肌あれである。一方この値が20以上であれば肌あれ
はほとんど認められない。(1) Skin conductance After washing the face with warm water of 37 ℃, in a room with temperature of 20 ℃ and humidity of 40%
After resting for 20 minutes, the water content of the stratum corneum was measured with a skin conductance meter (IBS). The smaller the conductance value is, the rougher the skin is, and when the conductance value is 5 or less, the skin is severely rough. On the other hand, if this value is 20 or more, skin roughness is hardly recognized.
(2) 肌あれスコア 肌あれを肉眼で観測し、下記基準により判定した。ス
コアは平均値で示した。(2) Rough skin score Rough skin was visually observed and judged according to the following criteria. The score is shown as an average value.
実施例8 実施例1〜6で得た化合物を用いて下記第2表に示す
組成の皮膚外用剤(乳化化粧料)を製造し、その肌あれ
改善効果を実施例7と同様の方法により評価した。結果
を第3表に示す。 Example 8 A skin external preparation (emulsified cosmetic) having the composition shown in Table 2 below was produced using the compounds obtained in Examples 1 to 6, and the skin roughening improving effect was evaluated by the same method as in Example 7. did. The results are shown in Table 3.
Claims (3)
岐鎖の飽和若しくは不飽和の炭化水素基または基−CH2C
H(OH)CH2OHを示す) で表わされるグリセリルエーテル誘導体。1. A general formula (I) (In the formula, R 1 is R 2 represents a hydrogen atom, a linear or branched saturated or unsaturated hydrocarbon group having 1 to 26 carbon atoms or a group —CH 2 C
H (OH) CH 2 OH) glyceryl ether derivative.
種または2種以上含有する皮膚外用剤。2. A glyceryl ether derivative according to claim 1
External preparation for skin containing one or more kinds.
外用剤。3. The external preparation for skin according to claim 2, which further contains a surfactant.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP25561288A JP2551471B2 (en) | 1988-10-11 | 1988-10-11 | Glyceryl ether derivative and skin external preparation containing the same |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP25561288A JP2551471B2 (en) | 1988-10-11 | 1988-10-11 | Glyceryl ether derivative and skin external preparation containing the same |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPH02104546A JPH02104546A (en) | 1990-04-17 |
| JP2551471B2 true JP2551471B2 (en) | 1996-11-06 |
Family
ID=17281161
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP25561288A Expired - Lifetime JP2551471B2 (en) | 1988-10-11 | 1988-10-11 | Glyceryl ether derivative and skin external preparation containing the same |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2551471B2 (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102766116A (en) * | 2012-07-13 | 2012-11-07 | 中国科学院宁波材料技术与工程研究所 | Dehydroabietylamine-based epoxy resin and preparation method and application thereof |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103965373B (en) * | 2014-04-21 | 2016-02-24 | 盐城工学院 | (2-hydroxyl-3-dehydrogenation fir oxygen base) propyl group chitooligosaccharide-and preparation method thereof |
| CN103923228B (en) * | 2014-04-21 | 2016-02-10 | 盐城工学院 | (2-hydroxyl-3-dehydrogenation fir oxygen base) hydroxypropyl hydroxyethyl chitosan and preparation method thereof |
| CN104059168B (en) * | 2014-05-07 | 2016-03-02 | 盐城工学院 | Allyldimethyl dehydroabietyl ammonium chloride graft shell oligose and preparation method thereof |
-
1988
- 1988-10-11 JP JP25561288A patent/JP2551471B2/en not_active Expired - Lifetime
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102766116A (en) * | 2012-07-13 | 2012-11-07 | 中国科学院宁波材料技术与工程研究所 | Dehydroabietylamine-based epoxy resin and preparation method and application thereof |
| CN102766116B (en) * | 2012-07-13 | 2014-09-17 | 中国科学院宁波材料技术与工程研究所 | Dehydroabietylamine-based epoxy resin and preparation method and application thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| JPH02104546A (en) | 1990-04-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP4358996B2 (en) | External preparation composition | |
| JPH04244042A (en) | Cosmetic composition | |
| JPWO2000061097A1 (en) | External preparation composition | |
| JPH0517399A (en) | Ester derivative and cosmetics containing the same | |
| JPH0676358B2 (en) | Amide derivative and external preparation for skin containing the same | |
| JP2551471B2 (en) | Glyceryl ether derivative and skin external preparation containing the same | |
| JPH0692293B2 (en) | External skin preparation | |
| JPH078844B2 (en) | Amide derivative and external preparation for skin containing the same | |
| US5446027A (en) | Amide derivative and external skin care preparation containing the same | |
| JPH0692296B2 (en) | External skin preparation | |
| JP4112741B2 (en) | Moisturizer | |
| JP2003206279A (en) | Pyridoxine derivative and skin care preparation and hair cosmetic containing the same pyridoxine derivative | |
| JP3447804B2 (en) | Benzal malonate derivative having organosilicon group, method for producing the same, ultraviolet absorber and cosmetic containing the same | |
| JP2704759B2 (en) | Glyceryl ether derivative and external preparation for skin containing the same | |
| JP3457813B2 (en) | Cosmetics | |
| JP4083688B2 (en) | Novel pseudo-ceramide and cosmetic composition containing the same | |
| JPH0696490B2 (en) | External skin composition | |
| WO1995027474A1 (en) | Dermatologic preparation | |
| JP3271828B2 (en) | Water-in-oil emulsion cosmetics | |
| JPH0692297B2 (en) | External skin preparation | |
| JPH0692294B2 (en) | External skin preparation | |
| JPH0717849A (en) | Wrinkle improver and keratinization improver | |
| JPH06157507A (en) | Amide derivative and skin external preparation containing the same | |
| JPH0585981A (en) | Pentaerythritol derivative, its production and cosmetic containing the same compound | |
| JP2001010921A (en) | Composition for external use |